Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

609
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
609
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

433
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
433
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

237
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
237
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

317
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
317
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

307
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
307
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

242
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
242

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Metastatic Malignant Melanoma Masquerading as Tolosa-Hunt Syndrome.

Case reports in ophthalmological medicine·2026
Same author

Redefining Obstructive Sleep Apnea: Treatment in the Modern Era.

Pathophysiology : the official journal of the International Society for Pathophysiology·2026
Same author

Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same author

From Spider Bite to Fungating Ulcerating Mass: An Aggressive Squamous Cell Carcinoma of the Face.

Cureus·2025
Same author

Fragmented Chemotherapy of Plasmablastic Lymphoma in an Immunocompromised Patient.

Cureus·2025
Same author

Post-Hospitalization Home Monitoring Programs During the COVID-19 Pandemic: Survey Results from the Hospital Medicine Re-engineering Network (HOMERuN).

Journal of general internal medicine·2023

相关实验视频

Updated: Jan 29, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.8K

血栓形成尽管有子脏性蛋白尿症.

Jose Redondo1, Alexander J Dobek1, Leonardo B Sosa1

  • 1Internal Medicine, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, USA.

Cureus
|January 28, 2026
PubMed
概括

患有子脏性蛋白尿和低白蛋白的患者可能面临高凝血风险,类似于脏性综合征. 这凸显了对这些人静脉血栓塞栓症 (VTE) 进行仔细管理的需要.

关键词:
aa 氨基粉症的发生低蛋白血症是什么意思周围的手术过程中使用抗凝剂.亚尼弗罗特蛋白尿症是什么静脉血栓塞栓症 (VTE) 是一种

更多相关视频

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.2K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.1K

相关实验视频

Last Updated: Jan 29, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.8K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.2K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.1K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 血液学 血液学 血液学
  • 内部医学 内部医学

背景情况:

  • 瘤综合征是已知的静脉血栓塞栓症 (VTE) 的风险因素.
  • 亚脏性蛋白尿和低albuminemia也越来越多地被认为有助于高凝固性.
  • 了解这些条件下的凝血风险对于患者管理至关重要.

研究的目的:

  • 要突出亚脏性蛋白尿症,低albuminemia和VTE风险增加之间的关联.
  • 介绍一个案例,说明即使在抗凝剂暂时中断时,VTE发展的潜力.
  • 强调需要一种全面的方法来管理患有病的患者的VTE风险.

主要方法:

  • 一个40岁的患者的病例报告显示,他患有阿纳萨卡,呼吸障碍和深静脉血栓 (DVTs).
  • 在活检之前暂时停止抗凝药时,对静脉瘤发作的临床观察.
  • 对患者的临床表现和诊断结果的审查.

主要成果:

  • 患者出现了双边下肢DVT和肺栓塞.
  • 在短暂停用抗凝药后出现了新的双边上肢DVT.
  • 在子脏性蛋白尿的背景下,低蛋白血症被认为是凝固风险的潜在指标.

结论:

  • 亚脏性蛋白尿和低albuminemia值得考虑作为VTE的显著风险因素.
  • 对于患有这些疾病的患者来说,谨慎的治疗策略是必不可少的,特别是当手术需要暂时停止抗凝剂时.
  • 建议采用多学科的方法,以优化这种患者群体的静脉瘤预防和治疗.